{
    "2019-04-17": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Gilead Collaborates With Insitro to Develop NASH Therapies",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Collaborates",
                        "Insitro",
                        "NASH",
                        "Therapies"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stock",
                        "GILD",
                        "Collaborates",
                        "NASH",
                        "FCSC",
                        "Surges",
                        "Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}